Anagenics Limited Targets Profitability with New Business Model

Anagenics Limited (AU:AN1) has released an update.

Anagenics Limited reported its Q1 FY25 financial performance, highlighting cash receipts of $2.1 million and a net operating cash outflow of $928,000. The company is focusing on restructuring its business model to achieve profitability and expects significant cost savings from Q2 FY25, aiming for a positive cash flow from November 2024. Anagenics continues to expand its health and beauty-tech business, enhancing shareholder value through global distribution of its anti-aging solutions.

For further insights into AU:AN1 stock, check out TipRanks’ Stock Analysis page.